3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphinooxazoline ligand compound, preparation method and uses of the same

A 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphinooxazoline ligand, being a enantiomer or a diastereoisomer of a compound represented by formula I:

• wherein R1 and R6 are each independently selected from the group consisting of hydrogen, C1-C10 alkyl or perfluoroalkyl, C3-C6 cycloalkyl, and C1-C4 alkoxy or perfluoroalkoxy;
• R2, R3, R4, and R5 are each independently selected from the group consisting of hydrogen, halogen, C1-C10 alkyl or perfluoroalkyl, and C3-C6 cycloalkyl;
• R7 is selected from the group consisting of hydrogen, C1-C10 alkyl or perfluoroalkyl, C3-C6 cycloalkyl, C6-C14 aryl, CMe2OBn, CMe2Ph, CMePh2, CPh3, CH(Ph)OMe, and CH(Ph)OBn;
• R8 and R9 are each independently selected from the group consisting of hydrogen, C1-C10 alkyl or perfluoroalkyl, C3-C6 cycloalkyl, C6-C14 aryl, CH2OCHPh2, CH2OCPh3, and CH2OCH2Ph;
• and R10 is selected from the group consisting of C1-C10 alkyl or perfluoroalkyl, C3-C6 cycloalkyl, and C6-C14 aryl.